Atlas Trials

Stage III Nasopharyngeal Carcinoma

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Nasopharyngeal Carcinoma

RecordFirmDate
Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer (NCT04231864)Alain Algazi2020-12-01
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer (NCT03049358)Stanford University2016-12-01
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510)University of Washington2015-10-08
Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA (NCT02135042)NRG Oncology2014-04-21

Track Stage III Nasopharyngeal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.